Salvatore Giovine

Chief Financial Officer, North America Innovative Medicine at Johnson and Johnson

Speaker

Sal Giovine is CFO, North America Innovative Medicine where he and his team are responsible for all Commercial aspects of J&J IM’s business in the US and Canada. Prior to this role Sal was CFO, Innovative Medicine External Innovation, responsible for providing financial leadership to M&A, Licensing, Corporate Venture and R&D transactions including J&J’s recent acquisition of Intra Cellular Therapies. Sal was previously CFO of Xilio Therapeutics, an immuno-oncology company, where he and his team led through the company’s IPO and where he was responsible for Finance and certain of the company’s operating functions. Prior to Xilio, over a 15 year-tenure at J&J, Sal held roles of increasing responsibility across Corporate as well as J&J’s Innovative Medicine and then Consumer Health businesses. Sal began his career in Public Accounting at Deloitte and hold a B.S. and M.B.A. from Fordham University in New York.